Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00721435 · ClinicalTrials.gov registry record · NA

Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions

A NA study of Breast Cancer and Mass Cystic, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
183
Enrollment target
2
Study locations

NCT00721435 is a NA study of Breast Cancer and Mass Cystic that has completed, run by University of Michigan. The registered enrollment target is 183 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00721435, a NA study of Breast Cancer and Mass Cystic, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
183 participants
Enrollment target
2
Study locations

Study Summary

The study will evaluate and refine a breast screening and diagnosis device.

Interventions

  • PROCEDURE 3D Tomosynthesis and ultrasound imaging

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor
  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2002-04
Est. Completion 2016-10
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT00721435

The ClinicalTrials.gov registry entry for NCT00721435 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which 3D Tomosynthesis and ultrasound imaging is the first listed.

NCT00721435 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT00721435 about?

NCT00721435 is a clinical study titled "Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions". The study will evaluate and refine a breast screening and diagnosis device.

What is the current status of trial NCT00721435?

This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2002-04. Estimated completion is 2016-10.

What conditions does trial NCT00721435 study?

This clinical trial studies the following conditions: Breast Cancer, Mass Cystic, Benign Mass.

What interventions are being tested in trial NCT00721435?

The interventions under investigation include: 3D Tomosynthesis and ultrasound imaging (PROCEDURE).

Who is sponsoring clinical trial NCT00721435?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00721435 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.